Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 662,473 |
|
|||||
| News | (1) | ||||||
| Day High | 50.98 | Low High |
|||||
| Day Low | 48.85 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Apellis Pharmaceuticals Inc | APLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 2.54 | 5.30% | 50.47 | 15:23:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 50.00 | 48.85 | 50.98 | 47.93 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,560 | 662,473 | $ 50.05 | $ 33,154,813 | - | 19.8301 - 94.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:23:01 | 2 | $ 50.43 | USD |
Apellis Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.08B | 120.58M | - | 396.59M | -525.63M | -4.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Apellis Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 47.52 | 50.98 | 46.53 | 48.43 | 1,099,009 | 2.95 | 6.21% |
| 1 Month | 58.66 | 59.91 | 46.40 | 51.90 | 1,197,669 | -8.19 | -13.96% |
| 3 Months | 61.60 | 71.90 | 46.40 | 60.05 | 1,314,835 | -11.13 | -18.07% |
| 6 Months | 47.56 | 73.80 | 41.19 | 58.09 | 1,786,820 | 2.91 | 6.12% |
| 1 Year | 84.95 | 94.75 | 19.8301 | 50.44 | 2,630,791 | -34.48 | -40.59% |
| 3 Years | 44.67 | 94.75 | 19.8301 | 51.30 | 1,733,175 | 5.80 | 12.98% |
| 5 Years | 19.20 | 94.75 | 16.85 | 47.45 | 1,347,229 | 31.27 | 162.86% |
Apellis Pharmaceuticals Description
| Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade. |
